Literature DB >> 21762119

Informative Dorfman screening.

Christopher S McMahan1, Joshua M Tebbs, Christopher R Bilder.   

Abstract

Since the early 1940s, group testing (pooled testing) has been used to reduce costs in a variety of applications, including infectious disease screening, drug discovery, and genetics. In such applications, the goal is often to classify individuals as positive or negative using initial group testing results and the subsequent process of decoding of positive pools. Many decoding algorithms have been proposed, but most fail to acknowledge, and to further exploit, the heterogeneous nature of the individuals being screened. In this article, we use individuals' risk probabilities to formulate new informative decoding algorithms that implement Dorfman retesting in a heterogeneous population. We introduce the concept of "thresholding" to classify individuals as "high" or "low risk," so that separate, risk-specific algorithms may be used, while simultaneously identifying pool sizes that minimize the expected number of tests. When compared to competing algorithms which treat the population as homogeneous, we show that significant gains in testing efficiency can be realized with virtually no loss in screening accuracy. An important additional benefit is that our new procedures are easy to implement. We apply our methods to chlamydia and gonorrhea data collected recently in Nebraska as part of the Infertility Prevention Project.
© 2011, The International Biometric Society.

Entities:  

Mesh:

Year:  2011        PMID: 21762119      PMCID: PMC3197971          DOI: 10.1111/j.1541-0420.2011.01644.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  24 in total

1.  Regression models for disease prevalence with diagnostic tests on pools of serum samples.

Authors:  S Vansteelandt; E Goetghebeur; T Verstraeten
Journal:  Biometrics       Date:  2000-12       Impact factor: 2.571

2.  Dual screening.

Authors:  W O Johnson; L M Pearson
Journal:  Biometrics       Date:  1999-09       Impact factor: 2.571

Review 3.  NAT screening of blood and plasma donations: evolution of technology and regulatory policy.

Authors:  Edward Tabor; Jay S Epstein
Journal:  Transfusion       Date:  2002-09       Impact factor: 3.157

4.  Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women.

Authors:  K A Kacena; S B Quinn; M R Howell; G E Madico; T C Quinn; C A Gaydos
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

5.  The use of a square array scheme in blood testing.

Authors:  R M Phatarfod; A Sudbury
Journal:  Stat Med       Date:  1994-11-30       Impact factor: 2.373

6.  Asymptomatic sexually transmitted diseases: the case for screening.

Authors:  Thomas A Farley; Deborah A Cohen; Whitney Elkins
Journal:  Prev Med       Date:  2003-04       Impact factor: 4.018

7.  Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism.

Authors:  Michael Schmidt; W Kurt Roth; Hermann Meyer; Erhard Seifried; Michael K Hourfar
Journal:  Transfusion       Date:  2005-03       Impact factor: 3.157

8.  Pooling of urine specimens allows accurate and cost-effective genetic detection of Chlamydia trachomatis in Lithuania and other low-resource countries.

Authors:  Rita Butylkina; Violeta Juseviciute; Giedre Kasparaviciene; Andrius Vagoras; Egidijus Pagirskas; Magnus Unemo; Marius Domeika
Journal:  Scand J Infect Dis       Date:  2007

9.  Pooling samples: the key to sensitive, specific and cost-effective genetic diagnosis of Chlamydia trachomatis in low-resource countries.

Authors:  Elena Shipitsyna; Kira Shalepo; Alevtina Savicheva; Magnus Unemo; Marius Domeika
Journal:  Acta Derm Venereol       Date:  2007       Impact factor: 4.437

10.  Blood screening for influenza.

Authors:  Michael Kai Hourfar; Anna Themann; Markus Eickmann; Pilaipan Puthavathana; Thomas Laue; Erhard Seifried; Michael Schmidt
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

View more
  24 in total

1.  Bayesian regression for group testing data.

Authors:  Christopher S McMahan; Joshua M Tebbs; Timothy E Hanson; Christopher R Bilder
Journal:  Biometrics       Date:  2017-04-12       Impact factor: 2.571

2.  A Note on the Minimax Solution for the Two-Stage Group Testing Problem.

Authors:  Yaakov Malinovsky; Paul S Albert
Journal:  Am Stat       Date:  2014-11-17       Impact factor: 8.710

3.  Regression models for group testing data with pool dilution effects.

Authors:  Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Biostatistics       Date:  2012-11-28       Impact factor: 5.899

4.  Two-stage hierarchical group testing for multiple infections with application to the infertility prevention project.

Authors:  Joshua M Tebbs; Christopher S McMahan; Christopher R Bilder
Journal:  Biometrics       Date:  2013-10-04       Impact factor: 2.571

5.  Regression analysis and variable selection for two-stage multiple-infection group testing data.

Authors:  Juexin Lin; Dewei Wang; Qi Zheng
Journal:  Stat Med       Date:  2019-07-11       Impact factor: 2.373

6.  Two-dimensional informative array testing.

Authors:  Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Biometrics       Date:  2011-12-29       Impact factor: 2.571

7.  Improved HIV-1 Viral Load Monitoring Capacity Using Pooled Testing With Marker-Assisted Deconvolution.

Authors:  Tao Liu; Joseph W Hogan; Michael J Daniels; Mia Coetzer; Yizhen Xu; Gerald Bove; Allison K DeLong; Lauren Ledingham; Millicent Orido; Lameck Diero; Rami Kantor
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-15       Impact factor: 3.731

8.  Prevalence estimation subject to misclassification: the mis-substitution bias and some remedies.

Authors:  Zhiwei Zhang; Chunling Liu; Sungduk Kim; Aiyi Liu
Journal:  Stat Med       Date:  2014-07-18       Impact factor: 2.373

9.  Group testing case identification with biomarker information.

Authors:  Dewei Wang; Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Comput Stat Data Anal       Date:  2018-02-01       Impact factor: 1.681

10.  Revisiting Nested Group Testing Procedures: New Results, Comparisons, and Robustness.

Authors:  Yaakov Malinovsky; Paul S Albert
Journal:  Am Stat       Date:  2018-06-04       Impact factor: 8.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.